1. No privatization. 2. Improvement on track. 3. Better financial this quarter 4. Debt reduction 5. 2018 second half to improve compared to 2017 Off we go, $0.30. Cheers
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025